Country: ITALY | Region: EUROPE | Type: Regulation | Keywords: #aifa #antiretrovirals #assogenerici #coronavirus #covid19 #drugshortages #farmindustria
PRICENTRIC BRIEF:
- Due to the sudden increase in demand for drugs amid the COVID-19 outbreak, Italy is currently experiencing drug supply deficiencies, and to find emergency solutions, the Italian Medicines Agency (AIFA) has turned to collaborating with pharmaceutical companies through Assogenerici and Farmindustria
- Enrique Hausermann, President of Assogenerici, explained that the need for muscle relaxants, anesthetics, opioids, and sedatives has increased drastically, along with the demand for antiretrovirals (ARVS), as these drugs are used in the management of patients in intensive care and for front-line treatment of COVID-19
- “The incisive increase in the request for medicines by hospitals to cope with the Coronavirus emergency is causing in recent weeks an overexertion of the production and distribution structure of the pharmaceutical sector, which however is reacting well,” said Hausermann
THE DETAILS
ROME, Italy – Due to the sudden increase in demand for drugs amid the COVID-19 outbreak, Italy is currently experiencing drug supply deficiencies. To find emergency solutions, the Italian Medicines Agency (AIFA) is collaborating with pharmaceutical companies through Assogenerici and Farmindustria.
AIFA is working with Italy’s Regions and autonomous provinces and giving priority to urgent cases of unavailability for which all necessary steps have been taken with regional tenders.
Enrique Hausermann, President of Assogenerici, explained that the need for muscle relaxants, anesthetics, opioids, and sedatives has increased drastically, along with the demand for antiretrovirals (ARVS), as these drugs are used in the management of patients in intensive care and for front-line treatment of COVID-19.
Hausermann said, “These are essential medicines for intensive and sub-intensive care units in the most affected regions. In the vast majority of cases, these are drugs that have been out of patent for some time, produced by several of our member companies.
“The incisive increase in the request for medicines by hospitals to cope with the Coronavirus emergency is causing in recent weeks an overexertion of the production and distribution structure of the pharmaceutical sector, which however is reacting well.”
Learn more about Pricentric One and our Global Pricing Solutions!
Contact us with your questions and global pricing needs, and an expert will follow up shortly.